Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Schedule of Quantitative Information of Fair Value Measurements (Details)

v3.24.3
Fair Value of Financial Instruments - Schedule of Quantitative Information of Fair Value Measurements (Details) - Significant Unobservable Inputs (Level 3)
$ in Thousands
Sep. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Liquidation | Accounts payable and accrued liabilities    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ (1,770)  
Liquidation | Minimum | Probability weighting of alternative outcomes | Accounts payable and accrued liabilities    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1000  
Liquidation | Maximum | Probability weighting of alternative outcomes | Accounts payable and accrued liabilities    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.5000  
Liquidation | Weighted Average | Probability weighting of alternative outcomes | Accounts payable and accrued liabilities    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.3897  
Total Level Three Debt Investments and Other Investment Receivables (Payables)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 3,378,808 $ 3,066,947
Debt Investments    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments 3,380,578 3,057,299
Debt Investments | Debt Investments originated within 6 months    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments 240,443 431,512
Debt Investments | Imminent Payoffs    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments 70,171 54,430
Debt Investments | Debt Investments Maturing in Less than One Year    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments 72,911 62,220
Debt Investments | Debt Investments in Wholly-Owned Subsidiaries    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments 47,633  
Equity and Warrant Investments    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments 113,393 116,916
Equity Investments | Market Comparable Companies    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 43,990 $ 52,094
Equity Investments | Market Comparable Companies | Minimum | EBITDA Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   12.3
Equity Investments | Market Comparable Companies | Minimum | Revenue Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.4 0.3
Equity Investments | Market Comparable Companies | Minimum | Tangible Book Value Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 1.6 1.8
Equity Investments | Market Comparable Companies | Minimum | Discount for Lack of Marketability    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1348 0.0711
Equity Investments | Market Comparable Companies | Maximum | EBITDA Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   12.3
Equity Investments | Market Comparable Companies | Maximum | Revenue Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 14.8 20.1
Equity Investments | Market Comparable Companies | Maximum | Tangible Book Value Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 1.6 1.8
Equity Investments | Market Comparable Companies | Maximum | Discount for Lack of Marketability    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.9282 0.9272
Equity Investments | Market Comparable Companies | Weighted Average | EBITDA Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   12.3
Equity Investments | Market Comparable Companies | Weighted Average | Revenue Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 13.4 7.2
Equity Investments | Market Comparable Companies | Weighted Average | Tangible Book Value Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 1.6 1.8
Equity Investments | Market Comparable Companies | Weighted Average | Discount for Lack of Marketability    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.3618 0.3157
Equity Investments | Market Adjusted OPM Backsolve    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 13,781 $ 11,096
Equity Investments | Market Adjusted OPM Backsolve | Minimum | Market Equity Adjustment    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input (0.8375) (0.8614)
Equity Investments | Market Adjusted OPM Backsolve | Maximum | Market Equity Adjustment    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.3035 0.3269
Equity Investments | Market Adjusted OPM Backsolve | Weighted Average | Market Equity Adjustment    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input (0.0848) 0.0747
Equity Investments | Discounted Cash Flow    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 33,234 $ 28,713
Equity Investments | Discounted Cash Flow | Minimum | Discount Rate    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1152 0.1988
Equity Investments | Discounted Cash Flow | Maximum | Discount Rate    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.3340 0.3197
Equity Investments | Discounted Cash Flow | Weighted Average | Discount Rate    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.3114 0.3051
Equity Investments | Other    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 3,012 $ 2,925
Warrants | Market Comparable Companies    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 15,466 $ 19,014
Warrants | Market Comparable Companies | Minimum | EBITDA Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   12.3
Warrants | Market Comparable Companies | Minimum | Revenue Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.9 0.9
Warrants | Market Comparable Companies | Minimum | Discount for Lack of Marketability    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1293 0.0621
Warrants | Market Comparable Companies | Maximum | EBITDA Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   12.3
Warrants | Market Comparable Companies | Maximum | Revenue Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 11.9 10.2
Warrants | Market Comparable Companies | Maximum | Discount for Lack of Marketability    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.3396 0.3312
Warrants | Market Comparable Companies | Weighted Average | EBITDA Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   12.3
Warrants | Market Comparable Companies | Weighted Average | Revenue Multiple    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 4.1 4.2
Warrants | Market Comparable Companies | Weighted Average | Discount for Lack of Marketability    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.2463 0.2170
Warrants | Market Adjusted OPM Backsolve    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 3,910 $ 3,074
Warrants | Market Adjusted OPM Backsolve | Minimum | Market Equity Adjustment    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input (0.6204) (0.7067)
Warrants | Market Adjusted OPM Backsolve | Maximum | Market Equity Adjustment    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.3035 0.3486
Warrants | Market Adjusted OPM Backsolve | Weighted Average | Market Equity Adjustment    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input (0.0140) 0.1317
Warrants | Other    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments   $ 0
Pharmaceuticals | Debt Investments | Market Comparable Companies    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 990,349 $ 971,775
Pharmaceuticals | Debt Investments | Market Comparable Companies | Minimum | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0990 0.1091
Pharmaceuticals | Debt Investments | Market Comparable Companies | Minimum | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input (0.0200) (0.0100)
Pharmaceuticals | Debt Investments | Market Comparable Companies | Maximum | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1655 0.2143
Pharmaceuticals | Debt Investments | Market Comparable Companies | Maximum | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0400 0.0350
Pharmaceuticals | Debt Investments | Market Comparable Companies | Weighted Average | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1274 0.1346
Pharmaceuticals | Debt Investments | Market Comparable Companies | Weighted Average | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0008 0.0004
Pharmaceuticals | Debt Investments | Liquidation    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments   $ 8,455
Pharmaceuticals | Debt Investments | Liquidation | Minimum | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   0.1000
Pharmaceuticals | Debt Investments | Liquidation | Maximum | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   0.5000
Pharmaceuticals | Debt Investments | Liquidation | Weighted Average | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   0.4183
Technology | Debt Investments | Market Comparable Companies    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 1,202,375 $ 1,181,823
Technology | Debt Investments | Market Comparable Companies | Minimum | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1008 0.1130
Technology | Debt Investments | Market Comparable Companies | Minimum | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input (0.0075) (0.0100)
Technology | Debt Investments | Market Comparable Companies | Maximum | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1919 0.2074
Technology | Debt Investments | Market Comparable Companies | Maximum | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0300 0.0500
Technology | Debt Investments | Market Comparable Companies | Weighted Average | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1326 0.1503
Technology | Debt Investments | Market Comparable Companies | Weighted Average | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0033 0.0047
Technology | Debt Investments | Liquidation    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 52,586 $ 0
Technology | Debt Investments | Liquidation | Minimum | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0500 1.0000
Technology | Debt Investments | Liquidation | Maximum | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 1.0000 1.0000
Technology | Debt Investments | Liquidation | Weighted Average | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.5786 1.0000
Technology | Debt Investments | Convertible Note Analysis    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 25,745 $ 23,244
Technology | Debt Investments | Convertible Note Analysis | Minimum | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0100 0.0100
Technology | Debt Investments | Convertible Note Analysis | Maximum | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.7000 0.5000
Technology | Debt Investments | Convertible Note Analysis | Weighted Average | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.5064 0.3932
Sustainable and Renewable Technology | Debt Investments | Market Comparable Companies    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 20,957 $ 1,678
Sustainable and Renewable Technology | Debt Investments | Market Comparable Companies | Minimum | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1213 0.1075
Sustainable and Renewable Technology | Debt Investments | Market Comparable Companies | Minimum | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0025 0.0075
Sustainable and Renewable Technology | Debt Investments | Market Comparable Companies | Maximum | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1566 0.1075
Sustainable and Renewable Technology | Debt Investments | Market Comparable Companies | Maximum | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0300 0.0075
Sustainable and Renewable Technology | Debt Investments | Market Comparable Companies | Weighted Average | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1543 0.1075
Sustainable and Renewable Technology | Debt Investments | Market Comparable Companies | Weighted Average | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0043 0.0075
Medical Devices | Debt Investments | Market Comparable Companies    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 55,413  
Medical Devices | Debt Investments | Market Comparable Companies | Minimum | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1223  
Medical Devices | Debt Investments | Market Comparable Companies | Minimum | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0000  
Medical Devices | Debt Investments | Market Comparable Companies | Maximum | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1319  
Medical Devices | Debt Investments | Market Comparable Companies | Maximum | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0050  
Medical Devices | Debt Investments | Market Comparable Companies | Weighted Average | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1265  
Medical Devices | Debt Investments | Market Comparable Companies | Weighted Average | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0028  
Lower Middle Market | Debt Investments | Market Comparable Companies    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments $ 601,995 $ 322,162
Lower Middle Market | Debt Investments | Market Comparable Companies | Minimum | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0866 0.1254
Lower Middle Market | Debt Investments | Market Comparable Companies | Minimum | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input (0.0025) (0.0075)
Lower Middle Market | Debt Investments | Market Comparable Companies | Maximum | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1968 0.2015
Lower Middle Market | Debt Investments | Market Comparable Companies | Maximum | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0325 0.0225
Lower Middle Market | Debt Investments | Market Comparable Companies | Weighted Average | Hypothetical Market Yield    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.1461 0.1413
Lower Middle Market | Debt Investments | Market Comparable Companies | Weighted Average | Premium/(Discount)    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input 0.0084 0.0056
Other Investment Receivable | Other Investment Receivables | Liquidation    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investments   $ 9,648
Other Investment Receivable | Other Investment Receivables | Liquidation | Minimum | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   0.1000
Other Investment Receivable | Other Investment Receivables | Liquidation | Maximum | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   0.5000
Other Investment Receivable | Other Investment Receivables | Liquidation | Weighted Average | Probability weighting of alternative outcomes    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]    
Investment company, investment owned, measurement input   0.4183